# A Safety and Tolerability Study of Denufosol in 2-4 Year Olds

> **NCT01181622** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 25 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** denufosol tetrasodium Inhalation Solution
- **DRUG:** 0.9% w/v sodium chloride solution

## Key facts

- **NCT ID:** NCT01181622
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2015-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181622, "A Safety and Tolerability Study of Denufosol in 2-4 Year Olds". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01181622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*